N Newron Pharmaceuticals S.p.A.: directors' dealings · Switzerland · SIX SER SIX:newron-pharmaceuticals-spa IT0004147952 CH CH · SIX SER
Explore the full directors' dealings record of Newron Pharmaceuticals S.p.A., a publicly traded company based in Switzerland. Shares are listed on CH CH, under the oversight of SIX SER. The latest transaction was disclosed on 2 December 2025 — Sale. Among the most active insiders: Anonymous (Non-executive member of the board of directors). Every trade is openly available.
€487,256
3 ops.
Sell Volume
Last declaration on 2 December 2025
Declarations 9 total
Executives ● Sale0 SIX
€111,553 5,465 shares @ €20.4123 IT0004147952⌘
SIX:T1PC200035 · 2 Dec 2025
Executives ● Sale0 SIX
€265,348 14,567 shares @ €18.2157
SIX:T1PBQ00061 · 26 Nov 2025
Executives ● Purchase0 SIX
€5,821 750 shares @ €7.7607 IT0004147952⌘
SIX:T1P4N000A0 · 23 Apr 2025
Ideal exit: 18 Jan 2026 (T+270) Executives ● Purchase0 SIX
€34,441 5,000 shares @ €6.8881 IT0004147952⌘
SIX:T1P4700052 · 7 Apr 2025
Ideal exit: 2 Jan 2026 (T+270) Executives ● Purchase0 SIX
€21,878 2,500 shares @ €8.7513 IT0004147952⌘
SIX:T1O6R00018 · 27 Jun 2024
Ideal exit: 24 Mar 2025 (T+270) Executives ● Purchase0 SIX
€25,519 2,502 shares @ €10.1995 IT0004147952⌘
SIX:T1O6P00046 · 25 Jun 2024
Ideal exit: 22 Mar 2025 (T+270) Executives ● Purchase0 SIX
€56,238 5,498 shares @ €10.2288 IT0004147952⌘
SIX:T1O6H00035 · 17 Jun 2024
Ideal exit: 14 Mar 2025 (T+270) Executives ● Purchase0 SIX
€21,290 2,000 shares @ €10.645 IT0004147952⌘
SIX:T1O6E00057 · 14 Jun 2024
Ideal exit: 11 Mar 2025 (T+270) Executives ● Sale0 SIX
€110,355 10,382 shares @ €10.6294 IT0004147952⌘
SIX:T1O5G000E3 · 16 May 2024